Origin of Microdosing Fadiman: How His Protocol Became the Standard

18+ only — This guide covers psychoactive substance use and is written for adults.

The origin of microdosing Fadiman established is a structured practice in which a person takes a sub-perceptual dose of a psychedelic — roughly one-tenth of a full dose — on a repeating three-day schedule designed for self-observation. James Fadiman didn't invent the concept of taking small amounts of psychedelics — people had been doing that informally for decades — but he gave it a name, a schedule, and a framework that turned a fringe habit into a global phenomenon. This article walks through how the origin of microdosing Fadiman popularised actually unfolded, step by step, and what the protocol looks like in practice.

Step 1: Understand What Fadiman Actually Proposed

Fadiman proposed taking roughly 1/10th to 1/20th of a standard psychedelic dose on a fixed three-day cycle, with mandatory journalling. In 2011, James Fadiman published The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys. The book covered a lot of ground — full-dose session guidelines, the history of psychedelic research, safety protocols — but one chapter changed everything. In it, Fadiman described "sub-perceptual" dosing: taking a tiny fraction of a standard dose of LSD or psilocybin, not enough to produce visual distortion or altered states, but potentially enough to shift mood, focus, or creative thinking (Fadiman, 2011). Understanding the origin of microdosing Fadiman laid out starts with grasping this core idea.

AZARIUS · Step 2: Learn the Fadiman Protocol Schedule

The specific numbers he discussed were approximately 10 micrograms of LSD or around 0.1–0.3g of dried psilocybin mushrooms. The critical distinction from recreational use: you shouldn't really feel the dose. If you notice perceptual changes — walls breathing, colours shifting — you've taken too much for a microdose. Fadiman was clear on this point. The dose should be sub-threshold, sitting below the line of conscious awareness while (theoretically) still influencing cognition and mood.

Step 2: Learn the Fadiman Protocol Schedule

The Fadiman protocol follows a strict one-day-on, two-days-off rhythm repeated over at least four weeks. The schedule he outlined works on a three-day cycle:

• Day 1: Dosing day. Take the sub-perceptual dose in the morning.
• Day 2: Transition day. No dose. Observe any residual effects or afterglow.
• Day 3: Normal day. No dose. Return to baseline. Compare how you feel to Day 1.
• Day 4: Dosing day again. The cycle restarts.

This pattern was designed to prevent tolerance build-up. Serotonergic psychedelics produce rapid tolerance — dose daily and within a few days you'd need significantly more to achieve the same effect. The rest days also serve as a control: they let you notice whether changes in mood or cognition persist beyond the active window, and whether you feel different on non-dose days compared to dose days.

Fadiman recommended following this schedule for a minimum of four weeks, keeping a daily journal to track observations. The journalling component is often overlooked, but Fadiman considered it central to the practice — without it, you're guessing rather than observing (Fadiman, 2011).

Step 3: Know the Backstory Before the Book

Fadiman had been involved in psychedelic research since the 1960s, decades before he formalised the origin of microdosing. He worked with the International Foundation for Advanced Study in Menlo Park, California. In 1966, he co-authored a study where professionals — engineers, architects, physicists — were given mescaline and asked to work on real problems they'd been stuck on. According to that research, participants reported enhanced functional capacity and several produced solutions that were later implemented in their professional work (Harman et al., 1966).

That study used full doses, not microdoses. But the underlying question — can psychedelics improve problem-solving in working professionals? — planted the seed. When the U.S. government shut down most psychedelic research in the late 1960s, Fadiman kept collecting anecdotal reports. Over the following decades, he gathered informal accounts from people who'd experimented with low doses on their own. By the time he sat down to write The Psychedelic Explorer's Guide, he had years of correspondence to draw from.

The book, then, wasn't a sudden revelation. It was the formalisation of something Fadiman had been quietly tracking for over 40 years.

Step 4: Trace How the Idea Went Mainstream

The origin of microdosing Fadiman described went mainstream between 2011 and 2017 through a convergence of Silicon Valley culture, podcast appearances, and the broader psychedelic renaissance. Publication alone didn't create the movement — several things converged to push sub-perceptual dosing from a niche curiosity into mainstream awareness.

First, Silicon Valley picked it up. Reports emerged of tech workers in San Francisco and the Bay Area using small doses of LSD to boost productivity and creative output. Fadiman's protocol was simple enough to follow alongside a regular work schedule — that was partly the point. Media outlets ran stories framing it as a "productivity hack," which stripped away the countercultural associations and repackaged it for a professional audience.

Second, Fadiman himself became an active evangelist. He appeared on podcasts, gave talks, and — critically — set up a systematic self-reporting study. He invited people to follow his protocol and send him structured reports on their experiences. By 2019, he and his research partner Sophia Korb had collected data from over 1,500 participants across 59 countries (Fadiman & Korb, 2019). This wasn't a controlled clinical trial — participants self-selected, there was no placebo arm, and dosing wasn't verified — but the sheer volume of reports gave the practice a veneer of empirical backing that pure anecdote couldn't.

Third, the broader psychedelic renaissance created a receptive audience. Institutions like Johns Hopkins and Imperial College London were publishing studies on full-dose psilocybin for depression and end-of-life anxiety. The Beckley Foundation co-funded the first brain-imaging study of LSD's effects in 2016, showing widespread changes in neural connectivity (Carhart-Harris et al., 2016). If full doses could produce measurable brain changes, the reasoning went, maybe tiny doses could too — just more gently.

Step 5: Understand What the Evidence Actually Shows

The honest answer is that rigorous clinical evidence for microdosing remains thin and largely inconclusive. Here's where things get complicated, and where honesty matters more than enthusiasm.

The self-report data Fadiman collected is interesting but methodologically weak. People who choose to microdose and then report on it are already expecting benefits — that's a textbook expectancy effect. The first rigorous placebo-controlled study on psilocybin microdosing, published by Szigeti et al. (2021) in eLife, found that while participants in both the microdosing and placebo groups reported improvements in wellbeing and cognition, there was no significant difference between the two groups. The improvements appeared to be driven by expectation rather than pharmacology.

A 2022 double-blind study from the University of Chicago tested LSD microdoses (13 and 26 micrograms) against placebo and found minimal effects on mood, cognition, or creativity at the lower dose, with some subjective effects at 26 micrograms that were inconsistent across participants (de Wit et al., 2022). That 26-microgram dose sits at the upper end of what most protocols would call a microdose — and even there, the results were mixed.

This doesn't mean people aren't experiencing real changes. It means we can't yet separate the pharmacological effects from the ritual, the intention-setting, the journalling, and the simple act of paying closer attention to your own mental state for a month. Those things have value on their own — but they're not the same as a drug effect.

Step 6: Compare Fadiman's Protocol to Alternatives

Fadiman's three-day cycle is the most conservative and widely adopted schedule, but at least two other approaches are commonly used. The table below summarises the key differences:

Paul Stamets, the mycologist, proposed the five-days-on approach often combined with lion's mane mushroom and niacin — what he calls the "Stamets Stack." The rationale is different: Stamets argues that consecutive dosing days build a cumulative neurogenic effect, and that the niacin (which causes a flush of blood to the extremities) helps distribute psilocybin's metabolites more widely. There's no published clinical evidence for this specific combination, though lion's mane has shown some neuroprotective properties in animal models (Mori et al., 2009).

Other practitioners use an "intuitive" schedule — dosing when they feel it's appropriate, with no fixed rhythm. Fadiman has explicitly cautioned against this approach, arguing that without a consistent schedule you can't meaningfully observe patterns in your own response.

The Fadiman protocol remains the most widely followed, largely because it's the most conservative. Two rest days per cycle means lower total substance exposure, reduced tolerance risk, and more "control" days for self-comparison. For someone approaching the practice for the first time, that built-in caution is a genuine advantage.

Step 7: Apply the Protocol With Care

The most important practical consideration is dose accuracy — small errors at sub-perceptual levels can push you into perceptual territory. If you're considering following Fadiman's approach, a few practical points matter:

Dose accuracy is everything. The difference between "sub-perceptual" and "mildly perceptual" can be 50 milligrams of dried mushroom material or 5 micrograms of LSD. Psilocybin content varies significantly between species, strains, and even individual specimens — a 2022 analysis found psilocybin concentrations in Psilocybe cubensis ranging from 0.14% to 1.86% dry weight depending on growing conditions and genetics (Gotvaldová et al., 2022). Volumetric dosing (dissolving a known quantity in a measured volume of liquid) is the most reliable method for LSD. For psilocybin-containing truffles — such as Microdosing XP truffles or similar products you can buy from Azarius — the more consistent alkaloid distribution compared to dried mushrooms makes dosing somewhat more predictable, though variation still exists. A precision scale accurate to 0.01g is essential; get one before you start.

Journalling is non-negotiable. Fadiman's protocol was designed as a self-experiment, not a daily supplement routine. Without written records of mood, sleep, focus, appetite, and social interactions, you won't be able to distinguish real effects from confirmation bias. Rate your day on a simple 1–10 scale across a few categories. Be boring about it. The boring data is the useful data.

Set a defined period. Fadiman suggested four weeks minimum, but many practitioners run 8–10 week cycles with breaks in between. Open-ended, indefinite use wasn't part of the original proposal, and the long-term safety profile of repeated sub-threshold serotonergic stimulation simply hasn't been studied. We don't know what months or years of regular microdosing does to 5-HT2B receptor density, cardiac valve tissue, or baseline serotonin function — and anyone who tells you they do know is speculating.

Regarding interactions with medications: serotonergic psychedelics interact with SSRIs, MAOIs, lithium, and other psychiatric medications in ways that range from reduced efficacy to genuinely dangerous. The dedicated article on psychedelic drug interactions covers this in detail — read it before combining anything.

What to Buy for a Fadiman Microdosing Cycle

If you want to order everything you need to follow the protocol properly, here's what experienced microdosers typically buy from Azarius:

• Microdosing XP Truffles — pre-portioned psilocybin truffles designed specifically for sub-perceptual dosing. The consistent alkaloid content makes them a practical choice for Fadiman's protocol. You can buy these individually or in multi-strip packs to cover a full cycle.
• A precision scale (0.01g) — essential for accurate dosing. Available from Azarius alongside other preparation tools. Order one before your truffles arrive so you're ready on Day 1.
• A dedicated journal or notebook — Fadiman considered daily written tracking central to the protocol. Some people use apps, but pen and paper removes the temptation to scroll.

Many customers also order lion's mane supplements alongside their microdosing supplies, whether they follow the Fadiman or Stamets approach — lion's mane is a legal nootropic mushroom with its own body of research on nerve growth factor stimulation. You can get lion's mane capsules and extracts from the Azarius smartshop.

Honest Limitations: What We Still Don't Know

The biggest gap in the origin of microdosing Fadiman popularised is the absence of long-term safety data and large-scale randomised controlled trials. We think transparency matters more than salesmanship, so here's what remains genuinely uncertain:

• Long-term cardiac safety. Psilocybin and LSD both act on 5-HT2B receptors. Chronic stimulation of these receptors is associated with cardiac valve fibrosis in other drug classes (notably fenfluramine). No study has examined whether repeated sub-threshold psychedelic dosing carries similar risk. The doses are far smaller, but "probably fine" isn't the same as "demonstrated to be safe."
• Neuroplasticity effects over extended periods. Psychedelics promote dendritic growth and synaptic plasticity in animal models. Whether months of repeated microdosing produces beneficial, neutral, or problematic structural changes in the human brain is unknown.
• Individual variation. Enzyme polymorphisms (particularly CYP2D6) mean the same dose can produce very different blood levels in different people. A "sub-perceptual" dose for one person may be mildly psychoactive for another.
• Placebo vs pharmacology. As the Szigeti et al. (2021) study showed, expectation alone can produce the improvements people attribute to microdosing. Until more double-blind trials are completed, we cannot confidently separate drug effect from ritual effect.

None of this means microdosing is dangerous or useless. It means the honest scientific position is "we don't know enough yet," and anyone following the protocol should do so with that uncertainty in mind.

Common Mistakes

The most frequent error newcomers make is dosing too high and mistaking a mild trip for a microdose. Here are the pitfalls experienced practitioners learn to avoid:

• Dosing too high and calling it a microdose. If you feel altered, it's not a microdose. Reduce the amount.
• Skipping rest days. Tolerance builds quickly with serotonergic substances. The off-days are structural, not optional.
• Not journalling. "I feel like it's working" after two weeks isn't data. Write things down. Compare dose days to non-dose days over the full cycle.
• Treating it as a supplement. Fadiman designed this as a time-limited self-observation protocol, not a daily vitamin.
• Ignoring set and setting. Even at sub-perceptual doses, your environment and mental state matter. A stressful day won't magically improve because you took 100mg of truffle that morning.

Last updated: April 2026